Molecular pathology of dystonia

Key Points

• Dystonia involves complex molecular pathology that affects neurotransmitter systems and muscle control.
• Key findings include the identification of specific genetic mutations associated with dystonia's onset and progression.
• Analysis of molecular pathways highlights how disruptions in neurotransmitter function contribute to dystonia's manifestations.
• Understanding these mechanisms may support the development of targeted therapies for managing dystonia symptoms.